IL6 and cancer: A small clinical pilot study comparing cancer patients without weight loss vs. cancer patients with weight loss showed that patients with cancer-associated weight loss had decreased abdominal adipocytes, higher circulating IL-6, increased lipolysis through the overexpression of the ATGL gene, and the browning of adipose tissue through the UCP-activating gene PGC-1α.